3
Announcements
Trials
Browse
Landscape
Status
Completed
456
Recruiting
171
Terminated
169
Active not recruiting
83
Unknown
62
Not yet recruiting
28
Withdrawn
22
Suspended
5
Available
3
No longer available
2
Enrolling by invitation
2
Approved for marketing
2
Temporarily not available
1
Sponsor Class
OTHER
6
INDUSTRY
2
NIH
1
Study Type
Observational
2
Sponsor
Cancer Type
Thoracic
2
Head & Neck
2
Gynecologic
2
Genitourinary
2
Gastrointestinal
2
Breast
2
Other solid neoplasm
1
Lymphoid
1
Dermatologic
1
CNS
1
Conditions
Neoplasms
12
Hematologic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Urinary Bladder Neoplasms
4
Leukemia, Myeloid, Acute
4
Colorectal Neoplasms
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Myasthenia Gravis
3
Multiple Myeloma
3
Lung Neoplasms
3
Kidney Neoplasms
3
Carcinoma, Hepatocellular
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Heart Failure
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Diabetes Mellitus, Type 2
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
INDUSTRY
×
Ovarian Neoplasms
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled
NCT06583395
2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
3,000 enrolled